Études

ESCAPE

Effect of alirocumab on the frequency of lipoprotein apheresis: a randomised Phase III trial

Domaine thérapeutique : PCSK9 inhibiteur

Pathologie : Dyslipidémie

DOCTORS

Does Optical Coherence Tomography Optimise Results of Stenting?

Domaine thérapeutique : Angioplastie

Pathologie : Insuffisance coronaire

AMERICA

Active detection and Management of the Extension of atherothrombosis in high Risk coronary patients in comparison with standard of Care for coronary Atherosclerosis

Domaine thérapeutique : Angioplastie

Pathologie : Insuffisance coronaire

PRAGUE-18

Randomized comparison of ticagrelor versus prasugrel in ST elevation myocardial infarction

Domaine thérapeutique : Antiagrégant

Pathologie : Insuffisance coronaire

Registre CLARIFY

Registre CLARIFY

Domaine thérapeutique : Antihypertenseurs

Pathologie : HTA

BASKET-SAVAGE

Basel Kosten Effektivitäts Trial – SAphenous Venous Graft Angioplasty Using Glycoprotein 2b/3a Receptor Inhibitors and Drug Eluting Stents

Domaine thérapeutique : Stent

Pathologie : Insuffisance coronaire

NORSTENT

Drug-eluting or bare-metal stentes for coronary artery disease

Domaine thérapeutique : Stent

Pathologie : Insuffisance coronaire

ANNEXA-4

Andexanet alfa for reversal of factor Xa inhibitors in patients with acute major bleeding

Domaine thérapeutique : Antidote AOD

Pathologie : Hémorragies

ENSURE-AF

Edoxaban vs enoxaparin/warfarin in subjects undergoing cardioversion of atrial fibrillation – the Randomizes ENSURE-AF Study

Domaine thérapeutique : Anticoagulant

Pathologie : Maladie coronaire

SAVE

The sleep apnea cardiovascular endpoints study results

Domaine thérapeutique : CPAP

Pathologie : Apnée du sommeil

Pages